$8.94
-0.04-0.45%
Last update: Nov 11, 4:28 AM
Teladoc Health Inc
TDOCNYSE
Teladoc Health rose 18.8% from $7.56 to $8.98, ahead of the S&P 500's +9.8%. Its worst day was Jul 30 (−28.3%), and its low came Feb 12 at $4.47.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Teladoc Health closed at its lowest level of the year, 40.9% below where the year started.
−4.5% · S&P 500 −1.5%
EPS of $-0.14 beat the $-0.21 estimate on $642.3M revenue (est. $634.8M); Q1 revenue guidance of $598.0M–$620.0M against the $632.9M consensus.
Story events cover the past 12 months · Times ET
+15.1% · S&P 500 −0.6%
EPS of $-0.36 beat the $-0.37 estimate on $613.8M revenue (est. $610.9M); FY revenue guidance of $2.5B–$2.6B against the $2.5B consensus.
+1.8% · S&P 500 +1.0%
Teladoc Health shares rose 14.0%, while the S&P 500 rose 0.6%.
+14.0% · S&P 500 +0.6%
Teladoc Health closed at its highest level of the year, 28.6% above where the year started.
+4.9% · S&P 500 +0.4%
EPS of $-0.21 beat the $-0.24 estimate on $606.9M revenue (est. $615.6M); Q3 revenue guidance of $569.0M–$609.0M against the $629.1M consensus.
−28.3%, the year's worst day, on 26M shares, the year's heaviest volume · S&P 500 +1.7%
EPS of $-0.15 beat the $-0.20 estimate on $605.1M revenue (est. $589.5M); Q4 revenue guidance of $569.0M–$615.0M against the $601.7M consensus.
+26.9%, the year's best day · S&P 500 −0.4%
Where it ended: a close of $8.98 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $-0.10, revenue est. $596.4M).
Nothing in the past 12 months.
All TDOC dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TDOC and SPY from Benzinga historical bars. Not investment advice.
